05/14
Headlines

Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

Mark Doerr02 mins

US specialty pharma firm Ariad Pharmaceuticals (NASDAQ:ARIA) has granted Israel’s Medison Pharma exclusive rights to commercialize Iclusig (ponatinib) in Israel for patients with Philadelphia-positive (Ph+) leukemias. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -12.09%. On last trading day company shares ended up $5.38. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day…

Read More

Biotech Volatile Stocks: BIND Therapeutics (NASDAQ:BIND), Oncomed Pharmaceuticals Inc (NASDAQ:OMED), Advaxis (NASDAQ:ADXS), Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

Chris Lewis02 mins

BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will report fourth quarter and year ended December 31, 2013 financial results on Tuesday, March 25, 2014. BIND Therapeutics Inc (NASDAQ:BIND) stock performance was 7.75% in last session and finished the day at $12.93. Traded volume…

Read More

Big Movers : Baidu Inc (ADR) (NASDAQ:BIDU), American International Group (NYSE:AIG), Williams-Sonoma Inc. (NYSE:WSM), Liberty Tax (NASDAQ:TAX), Tenneco Inc. (NYSE:TEN)

John Meady02 mins

Chinese Internet search giant Baidu Inc (ADR) (NASDAQ:BIDU) announced late Tuesday the appointment of Ya-Qin Zhang as president, in charge of new business, effective immediately. Zhang will report to Robin Li, Baidu’s chairman and chief executive officer. Baidu Inc (ADR) (NASDAQ:BIDU) belongs to Technology sector. Its net profit margin is 29.70% and weekly performance is…

Read More

Biotech Runners: MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), CytRx Corporation (NASDAQ:CYTR)

Adam Keintzel02 mins

MannKind Corporation (NASDAQ:MNKD) had its price objective reduced by Cowen and Company from $5.50 to $5.00 in a report released on Wednesday,Stock Ratings News reports. Analysts at Piper Jaffray downgraded shares of MannKind Corporation (NASDAQ:MNKD) from a neutral rating to an underweight rating in a research note on Monday. MannKind Corporation (NASDAQ:MNKD) stock performance was…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓